These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33921743)

  • 1.
    Löffler B; Tuchscherr L
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33921743
    [No Abstract]   [Full Text] [Related]  

  • 2. Community-acquired Staphylococcus aureus infections: Increasing virulence and emerging methicillin resistance in the new millennium.
    Stevens DL
    Curr Opin Infect Dis; 2003 Jun; 16(3):189-91. PubMed ID: 12821806
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting the host-pathogen interface for treatment of Staphylococcus aureus infection.
    Park B; Liu GY
    Semin Immunopathol; 2012 Mar; 34(2):299-315. PubMed ID: 22089960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise survey of Staphylococcus aureus virulence factors that promote adhesion and damage to peri-implant tissues.
    Arciola CR; Visai L; Testoni F; Arciola S; Campoccia D; Speziale P; Montanaro L
    Int J Artif Organs; 2011 Sep; 34(9):771-80. PubMed ID: 22094556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection.
    Shettigar K; Murali TS
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2235-2246. PubMed ID: 32683595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrotizing fasciitis caused by TSST-1 producing penicillin-sensitive Staphylococcus aureus--a case report.
    Omland LH; Rasmussen SW; Hvolris J; Friis-Møller A
    Acta Orthop; 2007 Apr; 78(2):296-7. PubMed ID: 17464622
    [No Abstract]   [Full Text] [Related]  

  • 7. [Molecular microbiology and clinical features of Staphylococcus aureus enterotoxins].
    Maródi CL; Rozgonyi F
    Orv Hetil; 2004 Oct; 145(44):2219-26. PubMed ID: 15626166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcal Enterotoxins Dose-Dependently Modulate the Generation of Myeloid-Derived Suppressor Cells.
    Stoll H; Ost M; Singh A; Mehling R; Neri D; Schäfer I; Velic A; Macek B; Kretschmer D; Weidenmaier C; Hector A; Handgretinger R; Götz F; Peschel A; Hartl D; Rieber N
    Front Cell Infect Microbiol; 2018; 8():321. PubMed ID: 30271756
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions between staphylococcal enterotoxins A and D and superantigen-like proteins 1 and 5 for predicting methicillin and multidrug resistance profiles among Staphylococcus aureus ocular isolates.
    Lu M; Parel JM; Miller D
    PLoS One; 2021; 16(7):e0254519. PubMed ID: 34320020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of Metabolic Interactions during
    Prince A; Wong Fok Lung T
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32917040
    [No Abstract]   [Full Text] [Related]  

  • 11. In silico Analysis of Toxins of Staphylococcus aureus for Validating Putative Drug Targets.
    Mohana R; Venugopal S
    Infect Disord Drug Targets; 2017; 17(2):130-142. PubMed ID: 28034364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of staphylococcal enterotoxin A in a fatal case of endocarditis.
    Ellis M; Serreli A; Colque-Navarro P; Hedstrom U; Chacko A; Siemkowicz E; Möllby R
    J Med Microbiol; 2003 Feb; 52(Pt 2):109-112. PubMed ID: 12543915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes.
    Cameron DR; Howden BP; Peleg AY
    Clin Infect Dis; 2011 Sep; 53(6):576-82. PubMed ID: 21865195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity.
    Cassat JE; Skaar EP
    Semin Immunopathol; 2012 Mar; 34(2):215-35. PubMed ID: 22048835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-inherent variability influences the transcriptional response of Staphylococcus aureus during in vivo infection.
    Thänert R; Goldmann O; Beineke A; Medina E
    Nat Commun; 2017 Feb; 8():14268. PubMed ID: 28155859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections.
    Varshney AK; Wang X; Scharff MD; MacIntyre J; Zollner RS; Kovalenko OV; Martinez LR; Byrne FR; Fries BC
    J Infect Dis; 2013 Dec; 208(12):2058-66. PubMed ID: 23922375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological and Clinical Evidence for the Role of Toxins in
    Bennett MR; Thomsen IP
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32575633
    [No Abstract]   [Full Text] [Related]  

  • 19. Are we close to a vaccination against Staphylococcus aureus?
    Merriman JA; Schlievert PM
    Future Microbiol; 2014; 9(6):717-20. PubMed ID: 25046518
    [No Abstract]   [Full Text] [Related]  

  • 20. HOST-PATHOGEN INTERACTION IN INFECTIONS DUE TO STAPHYLOCOCCUS AUREUS. STAPHYLOCOCCUS AUREUS VIRULENCE FACTORS.
    Drăgulescu EC; Codiţă I
    Roum Arch Microbiol Immunol; 2015; 74(1-2):46-64. PubMed ID: 26727854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.